Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools

Osteoclasts; culprits in inflammatory osteolysis

Steven L Teitelbaum

Arthritis Research & Therapy 2006, 8:201 doi:10.1186/ar1857

Accesses  

  • Last 30 days: 52 accesses
  • Last year: 518 accesses
  • All time: 5142 accesses

Cited by

BioMed Central: 3 citations

Research article   Open Access

RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro

Karen A Sutherland, Helena L Rogers, Denise Tosh, Michael J Rogers Arthritis Research & Therapy 2009, 11:R58 (30 April 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article   Open Access

Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis

Letizia Penolazzi, Ilaria Lampronti, Monica Borgatti, Mahmud Khan, Margherita Zennaro, Roberta Piva, Roberto Gambari BMC Complementary and Alternative Medicine 2008, 8:59 (30 October 2008)

Abstract | Full text | PDF | PubMed | Editor’s summary

Extracts of Emblica officinalis fruits induce apoptosis of mature osteoclasts by interfering with the activity of the transcription factor NF-kB without altering osteoclastogenesis, and could provide an alternative therapeutic approach for the treatment of bone loss disorders.

Research article   Open Access Highly Accessed

TNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood

Qian Zhang, Ruolin Guo, Edward M Schwarz, Brendan F Boyce, Lianping Xing Arthritis Research & Therapy 2008, 10:R37 (27 March 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations